| scholarly article | Q13442814 |
| P50 | author | Zefen Xiao | Q87993640 |
| P2093 | author name string | Lan Wang | |
| Lei Deng | |||
| Ping Wang | |||
| Xin Wang | |||
| Yu Lin | |||
| Xinchen Sun | |||
| Chen Li | |||
| Jun Liang | |||
| Wencheng Zhang | |||
| Wenqing Wang | |||
| Qingsong Pang | |||
| Xiaomin Wang | |||
| Junqiang Chen | |||
| Xiao Chang | |||
| Xiaolin Ge | |||
| Wenjie Ni | |||
| Zongmei Zhou | |||
| Chun Han | |||
| Yidian Zhao | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| FUNCTIONAL EVALUATION: THE BARTHEL INDEX | Q28201591 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
| Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients | Q33571196 | ||
| S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis | Q33605846 | ||
| The comprehensive geriatric assessment: when, where, how. | Q33861566 | ||
| The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation | Q34329108 | ||
| Geriatric oncology: a clinical approach to the older patient with cancer. | Q35111415 | ||
| Comprehensive geriatric assessment | Q35599061 | ||
| Utilization of comprehensive geriatric assessment in cancer patients | Q35634086 | ||
| Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). | Q36220834 | ||
| Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. | Q36977519 | ||
| Failure patterns in patients with esophageal cancer treated with definitive chemoradiation | Q37105819 | ||
| Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study | Q37225652 | ||
| Esophagectomy for cancer in octogenarians. | Q37764918 | ||
| Systematic review and pooled analysis assessing the association between elderly age and outcome following surgical resection of esophageal malignancy. | Q38010466 | ||
| High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis | Q38559388 | ||
| The MOS social support survey | Q39513264 | ||
| Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo | Q39650364 | ||
| Esophageal cancer dose escalation using a simultaneous integrated boost technique | Q39820035 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer | Q40874972 | ||
| Development and testing of a five-item version of the Geriatric Depression Scale | Q41679013 | ||
| Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study | Q41768209 | ||
| Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer | Q47805138 | ||
| Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. | Q47822925 | ||
| Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study | Q48839251 | ||
| Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. | Q51742449 | ||
| A controlled trial of inpatient and outpatient geriatric evaluation and management. | Q51958769 | ||
| Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer. | Q53030851 | ||
| Senior adult oncology clinical practice guidelines in oncology | Q60152840 | ||
| A large proportion of esophageal cancer cases and the incidence difference between regions are attributable to lifestyle risk factors in China | Q64128024 | ||
| Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
| Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus | Q68122887 | ||
| Management of cancer in the older person: a practical approach | Q73964368 | ||
| Body mass index and mortality among hospitalized patients | Q74352991 | ||
| INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy | Q77706014 | ||
| Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study | Q87416279 | ||
| Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q88406083 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | study protocol | Q111908491 |
| P304 | page(s) | 397 | |
| P577 | publication date | 2019-04-29 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol | |
| P478 | volume | 19 |
| Q64282154 | Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study prot | cites work | P2860 |
Search more.